Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production
Abstract
Lipopolysaccharide is a major constituent of the outer membrane of Gram-negative bacteria and important in the induction of pro-inflammatory responses. Recently, novel LPS species derived from Neisseria meningitidis H44/76 by insertional inactivation of the lpxL1 and lpxL2 genes have been created with a lipid A portion consisting of five (penta-acylated lpxL1 ) or four (tetra-acylated lpxL2 ) fatty acids connected to the glucosamine backbone instead of six fatty acids in the wild-type LPS. We show that these mutant LPS-types are poor inducers of cytokines (tumor-necrosis factor-α, IL-1β, IL-10, IL-RA) in human mononuclear cells. Both penta- and tetra-acylated meningococcal LPSs were able to inhibit cytokine production by wild-type Escherichia coli or meningococcal LPS. Binding of FITC-labelled E. coli LPS TLR4 transfected Chinese hamster ovary (CHO) cells was inhibited by both mutant LPS-types. Experiments with CHO fibroblasts transfected with human CD14 and TLR4 showed that the antagonizing effect was dependent on the expression of human TLR4. In contrast to the situation in humans, lpxL1 LPS has agonistic activity for cytokine production in peritoneal macrophages of DBA mice, and exacerbated arthritis in murine collagen induced arthritis model. N. meningitidis lipid A mutant LPSs lpxL1 and lpxL2 function as LPS antagonists in humans by inhibiting TLR4-dependent cytokine production but have agonistic activity in mice.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hexa-acylated LPS potently activates human TLR4/MD2, whereas hypo-acylated tetra- and penta-acylated LPS poorly activate or antagonize human TLR4/MD2 activation driven by hexa-acylated LPS.
“it has been previously shown that hexa-acylated LPS potently activates human TLR4/MD2, whereas hypo-acylated tetra- and penta-acylated LPS poorly activate or antagonize human TLR4/MD2 activation driven by hexa-acylated LPS22,23.”
From Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses (2025) · cites this paper as [23]
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in <i>Tlr4</i> Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631 · see citing works
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,986 · see citing works
Westphal, O. (1965) · Medical Entomology and Zoology · Cited by 2,537 · see citing works
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,187 · see citing works
Hirschfeld, M. J., Ma, Y., Weis, J. H., Vogel, S. N., & Weis, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.618 · Cited by 1,155 · see citing works
Essential role of MD-2 in LPS responsiveness and TLR4 distribution
Nagai, Y., Akashi, S., Nagafuku, M., Ogata, M., Iwakura, Y., Akira, S., Kitamura, T., Kosugi, A., Kimoto, M., & Miyake, K. (2002) · Nature Immunology · doi:10.1038/ni809 · Cited by 1,021 · see citing works
Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.
Lien, E., Means, T., Heine, H., Yoshimura, A., Kusumoto, S., Fukase, K., Fenton, M., Oikawa, M., Qureshi, N., Monks, B., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8541 · Cited by 798 · see citing works
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.144-166.2000 · Cited by 585 · see citing works
Self-citationJoosten, L. A. B., Helsen, M. M. A., van de Loo, F. A. J., & van den Berg, W. B. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23363 · Cited by 506 · see citing works
Self-citationLipid A-like molecules that antagonize the effects of endotoxins on human monocytes.
Golenbock, D. T., Hampton, R. Y., Qureshi, N., Takayama, K., & Raetz, C. R. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55023-7 · Cited by 417 · see citing works
Joosten, L. A. B., Helsen, M. M. A., van de Loo, F. A. J., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390513 · Cited by 403 · see citing works
Self-citationComparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors
Matsushima, N., Tanaka, T., Enkhbayar, P., Mikami, T., Taga, M., Yamada, K., & Kuroki, Y. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-124 · Cited by 394 · see citing works
E5531, a Pure Endotoxin Antagonist of High Potency
Christ, W. J., Asano, O., Robidoux, A. L. C., Perez, M., Wang, Y., Dubuc, G. R., Gavin, W. E., Hawkins, L. D., McGuinness, P. D., Mullarkey, M. A., et al. (1995) · Science · doi:10.1126/science.7701344 · Cited by 319 · see citing works
Inhibition of toll‐like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis
Abdollahi‐Roodsaz, S., Joosten, L. A. B., Roelofs, M. F., Radstake, T. R. D. J., Matera, G., Popa, C. D., van der Meer, J. W. M., Netea, M. G., & van den Berg, W. B. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22848 · Cited by 303 · see citing works
Self-citationDrenth, J. P. H., Uum, S. H. M. V., van Deuren, M., Pesman, G. J., van der Ven‐Jongekrijg, J., & van der Meer, J. W. (1995) · Journal of Applied Physiology · doi:10.1152/jappl.1995.79.5.1497 · Cited by 294 · see citing works
Self-citationEvidence for an Accessory Protein Function for Toll-Like Receptor 1 in Anti-Bacterial Responses
Wyllie, D. H., Kiss‐Toth, E., Visintin, A., Smith, S. C., Boussouf, S., Segal, D. M., Duff, G. W., & Dower, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7125 · Cited by 266 · see citing works
Fredriksen, J. H., Rosenqvist, E., Wedege, E., Bryn, K., BJUNE, G., Frøholm, L. O., Lindbak, A.-K., Møgster, B., Namork, E., & Rye, U. (1991) · PubMed · Cited by 242 · see citing works
Fort, M. M., Mozaffarian, A., Stöver, A. G., Correia, J. D. S., Johnson, D. A., Crane, R. T., Ulevitch, R. J., Persing, D. H., Bielefeldt-Ohmann, H., Probst, P., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6416 · Cited by 216 · see citing works
van der Ley, P., Steeghs, L., Hamstra, H.-J., ten Hove, J., Zomer, B., & van Alphen, L. (2001) · Infection and Immunity · doi:10.1128/iai.69.10.5981-5990.2001 · Cited by 215 · see citing works
Self-citationDziarski, R., Wang, Q., Miyake, K., Kirschning, C. J., & Gupta, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1938 · Cited by 212 · see citing works
Functions of Toll-like receptors: lessons from KO mice
Akira, S., & Takeda, K. (2004) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2004.04.002 · Cited by 179 · see citing works
CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition.
Delude, R. L., Savedra, R., Zhao, H., Thieringer, R., Yamamoto, S., Fenton, M. J., & Golenbock, D. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9288 · Cited by 178 · see citing works
Coats, S. R., Pham, T.-T. T., Bainbridge, B. W., Reife, R. A., & Darveau, R. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4490 · Cited by 169 · see citing works
Holten, E. (1979) · Journal of Clinical Microbiology · doi:10.1128/jcm.9.2.186-188.1979 · Cited by 167 · see citing works
Zughaier, S. M., Tzeng, Y., Zimmer, S. M., Datta, A., Carlson, R. W., & Stephens, D. S. (2003) · Infection and Immunity · doi:10.1128/iai.72.1.371-380.2004 · Cited by 156 · see citing works
Yoshimura, A., Kaneko, T., Kato, Y., Golenbock, D. T., & Hara, Y. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.218-225.2002 · Cited by 156 · see citing works
Medvedev, A. E., Henneke, P., Schromm, A. B., Lien, E., Ingalls, R. R., Fenton, M. J., Golenbock, D. T., & Vogel, S. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2257 · Cited by 155 · see citing works
Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants
Alving, C. R. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80355-4 · Cited by 151 · see citing works
Molecular Basis of Reduced Potency of Underacylated Endotoxins
Teghanemt, A., Zhang, D., Levis, E. N., Weiss, J. P., & Gioannini, T. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4669 · Cited by 149 · see citing works
Activation of Mammalian Toll-like Receptors by Endogenous Agonists
Johnson, G. B., Brunn, G. J., & Platt, J. L. (2003) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v23.i12.20 · Cited by 143 · see citing works
Chemical structure and immunobiological activity of Porphyromonas gingivalis lipid A
Ogawa, T. (2007) · Frontiers in bioscience · doi:10.2741/2353 · Cited by 101 · see citing works
Invited review: Neisseria meningitidis lipopolysaccharides in human pathology
Brandtzaeg, P., Bjerre, A. K., Øvstebø, R., Brusletto, B. S., Joø, G. B., & Kierulf, P. (2001) · Journal of Endotoxin Research · doi:10.1177/09680519010070060401 · Cited by 99 · see citing works
Delude, R. L., Yoshimura, A., Ingalls, R. R., et al. (1998) · PubMed · Cited by 92 · see citing works
Bartonella quintanaLipopolysaccharide Is a Natural Antagonist of Toll-Like Receptor 4
Popa, C. D., Abdollahi‐Roodsaz, S., Joosten, L. A. B., Takahashi, N., Sprong, T., Matera, G., Liberto, M. C., Focà, A., van Deuren, M., Kullberg, B. J., et al. (2007) · Infection and Immunity · doi:10.1128/iai.00237-07 · Cited by 86 · see citing works
Self-citationProhinar, P., Re, F., Widstrom, R. L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609400200 · Cited by 85 · see citing works
Delude, R. L., Yoshimura, A., Ingalls, R. R., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3001 · Cited by 85 · see citing works
Bunnell, E., Lynn, M., Habet, K. J., et al. (2000) · Critical Care Medicine · doi:10.1097/00003246-200008000-00005 · Cited by 83 · see citing works
Ingalls, R., Lien, E., & Golenbock, D. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2230-2236.2001 · Cited by 83 · see citing works
Macagno, A., Molteni, M., Rinaldi, A., Bertoni, F., Lanzavecchia, A., Rossetti, C., & Sallusto, F. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060136 · Cited by 79 · see citing works
Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritisin mice
Yoshino, S., Sasatomi, E., & Ohsawa, M. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00015.x · Cited by 77 · see citing works
Steeghs, L., Keestra, A. M., van Mourik, A., et al. (2008) · Infection and Immunity · doi:10.1128/iai.00005-08 · Cited by 75 · see citing works
Savov, J. D., Brass, D. M., Lawson, B. L., McElvania, E., Walker, J. K. L., & Schwartz, D. A. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00014.2005 · Cited by 73 · see citing works
Host species-specific usage of the TLR4-LPS receptor complex
Lizundia, R., Sauter, K., Taylor, G., & Werling, D. (2008) · Innate Immunity · doi:10.1177/1753425908095957 · Cited by 59 · see citing works
Humphries, H. E., Triantafilou, M., Makepeace, B. L., Heckels, J. E., Triantafilou, K., & Christodoulides, M. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00471.x · Cited by 45 · see citing works
Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4
Zimmer, S. M., Zughaier, S. M., Tzeng, Y., et al. (2007) · Glycobiology · doi:10.1093/glycob/cwm057 · Cited by 30 · see citing works
Grebenchtchikov, N., van der Ven-Jongekrijg, J., Pesman, G. J., et al. (2005) · PubMed · doi:10.2427/6035 · Cited by 19 · see citing works
Sprong, T., van der Ley, P., Steeghs, L., et al. (2003) · PubMed · Cited by 17 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses
Sardar, P., Beresford-Jones, B. S., Xia, W., Shabana, O., Suyama, S., Ramos, R. J. F., Soderholm, A. T., Tourlomousis, P., Kuo, P., Evans, A. C., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-01930-y · Cited by 49 · see citing works
- Authors
- Sprong, T., Ley, P. V. D., Abdollahi-Roodsaz, S., Joosten, L., Meer, J. V. D., Netea, M., & Deuren, M. V.
- Affiliations
- Radboud University Nijmegen (NL)
- National Institute for Vaccine Development, Bilthoven, The Netherlands
- Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
- Corresponding author
- Sprong, Tom
- Venue
- Innate Immunity
- Publisher
- SAGE Publications
- Published
- 2010-11-18
- Volume
- 17
- Issue
- 6
- Pages
- 517-525
- ISSN
- 1753-4259 (ISSN-L)
- 1753-4267
- OpenAlex
- W2144252752
- Cited by
- 20
- References
- 47
- Citations by year
- 2026: 3 · 2025: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2016: 2 · 2014: 3 · 2013: 4 · 2012: 2
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Innate Immunity (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Rivm Repository (Netherlands National Institute for Public Health and the Environment) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Neisseria meningitidis, lipid A, TLR4, cytokine production, TNF-α, interleukin-1, IL-10, CD14, human mononuclear cells, peritoneal macrophages, collagen-induced arthritis
- MeSH terms
- Acyltransferases, Animals, Arthritis, Experimental, Bacterial Proteins, Cricetulus, Cricetinae, Humans, Leukocytes, Mononuclear, Lipid A, Lipopolysaccharides, Mice, Inbred DBA, Neisseria meningitidis, Transfection, Cytokines, Mutagenesis, Insertional, CHO Cells, Macrophages, Peritoneal, Toll-Like Receptor 4, Mice, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review